Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle [Diabetic nephropathy: Interprofessional support of medication adherence]
Fiche du document
31 mai 2023
- doi: 10.53738/REVMED.2023.19.829.1085
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.829.1085
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37260204
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4D4B823B11B75
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-12-01 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
PatientesCiter ce document
C. Bandiera et al., « Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle [Diabetic nephropathy: Interprofessional support of medication adherence] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.829.1085
Métriques
Partage / Export
Résumé
Medication non-adherence in patients with diabetic kidney disease (DKD) is endemic. The PANDIA-IRIS study, implemented at the community pharmacy of Unisanté, illustrates the support of medication adherence in patients with DKD by pharmacists, through an interprofessional program (IMAP) based on a behavioral science theoretical framework. Implementing behavioural support programmes such as PANDIA-IRIS on a large scale in Switzerland is both a necessity and a challenge. These programmes should be an integral part of standard patient care. The transition of care towards interprofessional collaborations and a clarification of roles in supporting adherence, including the patient as a partner, will contribute to fully considering adherence in therapeutic decision making and support to enable better achievement of long-term clinical goals.